Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05267600 |
|---|---|
| Brief Title: | A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid (BALLAD) |
| First Submitted : | February 14, 2022 |
| First Submitted that Met QC Criteria : | February 23, 2022 |
| First Posted : | March 4, 2022 |
| Last Update Submitted that Met QC Criteria : | January 16, 2024 |
| Last Update Posted : | January 17, 2024 |